663 related articles for article (PubMed ID: 23903700)
1. Cellular mechanisms of tissue fibrosis. 5. Novel insights into liver fibrosis.
Mallat A; Lotersztajn S
Am J Physiol Cell Physiol; 2013 Oct; 305(8):C789-99. PubMed ID: 23903700
[TBL] [Abstract][Full Text] [Related]
2. What's new in liver fibrosis? The origin of myofibroblasts in liver fibrosis.
Iwaisako K; Brenner DA; Kisseleva T
J Gastroenterol Hepatol; 2012 Mar; 27 Suppl 2(Suppl 2):65-8. PubMed ID: 22320919
[TBL] [Abstract][Full Text] [Related]
3. Cellular and molecular mechanisms in the pathogenesis of liver fibrosis: An update.
Elpek GÖ
World J Gastroenterol; 2014 Jun; 20(23):7260-76. PubMed ID: 24966597
[TBL] [Abstract][Full Text] [Related]
4. Origin and function of myofibroblasts in the liver.
Wells RG; Schwabe RF
Semin Liver Dis; 2015 May; 35(2):97-106. PubMed ID: 25974896
[TBL] [Abstract][Full Text] [Related]
5. Liver fibrogenesis and the role of hepatic stellate cells: new insights and prospects for therapy.
Li D; Friedman SL
J Gastroenterol Hepatol; 1999 Jul; 14(7):618-33. PubMed ID: 10440206
[TBL] [Abstract][Full Text] [Related]
6. Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues.
Parola M; Pinzani M
Mol Aspects Med; 2019 Feb; 65():37-55. PubMed ID: 30213667
[TBL] [Abstract][Full Text] [Related]
7. Autophagy: a multifaceted partner in liver fibrosis.
Mallat A; Lodder J; Teixeira-Clerc F; Moreau R; Codogno P; Lotersztajn S
Biomed Res Int; 2014; 2014():869390. PubMed ID: 25254217
[TBL] [Abstract][Full Text] [Related]
8. The origin of fibrogenic myofibroblasts in fibrotic liver.
Kisseleva T
Hepatology; 2017 Mar; 65(3):1039-1043. PubMed ID: 27859502
[TBL] [Abstract][Full Text] [Related]
9. ERK Pathway in Activated, Myofibroblast-Like, Hepatic Stellate Cells: A Critical Signaling Crossroad Sustaining Liver Fibrosis.
Foglia B; Cannito S; Bocca C; Parola M; Novo E
Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31159366
[TBL] [Abstract][Full Text] [Related]
10. Hepatic fibrosis: It is time to go with hepatic stellate cell-specific therapeutic targets.
Ezhilarasan D; Sokal E; Najimi M
Hepatobiliary Pancreat Dis Int; 2018 Jun; 17(3):192-197. PubMed ID: 29709350
[TBL] [Abstract][Full Text] [Related]
11. CREB family: A significant role in liver fibrosis.
Li G; Jiang Q; Xu K
Biochimie; 2019 Aug; 163():94-100. PubMed ID: 31112743
[TBL] [Abstract][Full Text] [Related]
12. Recent advancement of molecular mechanisms of liver fibrosis.
Seki E; Brenner DA
J Hepatobiliary Pancreat Sci; 2015 Jul; 22(7):512-8. PubMed ID: 25869468
[TBL] [Abstract][Full Text] [Related]
13. Cellular and molecular mechanisms in liver fibrogenesis.
Novo E; Cannito S; Paternostro C; Bocca C; Miglietta A; Parola M
Arch Biochem Biophys; 2014 Apr; 548():20-37. PubMed ID: 24631571
[TBL] [Abstract][Full Text] [Related]
14. Matricellular protein CCN1 promotes regression of liver fibrosis through induction of cellular senescence in hepatic myofibroblasts.
Kim KH; Chen CC; Monzon RI; Lau LF
Mol Cell Biol; 2013 May; 33(10):2078-90. PubMed ID: 23508104
[TBL] [Abstract][Full Text] [Related]
15. Clinical Advancements in the Targeted Therapies against Liver Fibrosis.
Bansal R; Nagórniewicz B; Prakash J
Mediators Inflamm; 2016; 2016():7629724. PubMed ID: 27999454
[TBL] [Abstract][Full Text] [Related]
16. SOX9 predicts progression toward cirrhosis in patients while its loss protects against liver fibrosis.
Athwal VS; Pritchett J; Llewellyn J; Martin K; Camacho E; Raza SM; Phythian-Adams A; Birchall LJ; Mullan AF; Su K; Pearmain L; Dolman G; Zaitoun AM; Friedman SL; MacDonald A; Irving WL; Guha IN; Hanley NA; Piper Hanley K
EMBO Mol Med; 2017 Dec; 9(12):1696-1710. PubMed ID: 29109128
[TBL] [Abstract][Full Text] [Related]
17. Pathobiology of liver fibrosis: a translational success story.
Lee YA; Wallace MC; Friedman SL
Gut; 2015 May; 64(5):830-41. PubMed ID: 25681399
[TBL] [Abstract][Full Text] [Related]
18.
Hsu WH; Liao SC; Chyan YJ; Huang KW; Hsu SL; Chen YC; Siu ML; Chang CC; Chung YS; Huang CF
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31137784
[TBL] [Abstract][Full Text] [Related]
19. The characteristics of activated portal fibroblasts/myofibroblasts in liver fibrosis.
Karin D; Koyama Y; Brenner D; Kisseleva T
Differentiation; 2016 Sep; 92(3):84-92. PubMed ID: 27591095
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA function in the profibrogenic interplay upon chronic liver disease.
Huang J; Yu X; Fries JW; Zhang L; Odenthal M
Int J Mol Sci; 2014 May; 15(6):9360-71. PubMed ID: 24871365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
